Email This Article
Headlines & Perspectives
Biotech Notebook: Impotence-Drug Stock Zonagen Suffers from Ups and Downs
By
Jesse Eisinger
02/24/99 - 03:09 PM EST
In addition, a potential Isis offering has some investors concerned, but the company says not to worry.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Find more premium investing ideas